LIANN WEINER: Open Payments
NPI 1124571435 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 16 payments from 11 companies in 2025. Trend: 2023 $426 · 2024 $670 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 3 | $76 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| Janssen Biotech, Inc. | 2 | $38 |
| PFIZER INC. | 2 | $35 |
| GENZYME CORPORATION | 1 | $31 |
| JAZZ PHARMACEUTICALS INC. | 1 | $28 |
| Syndax Pharmaceuticals, Inc. | 1 | $21 |
| SOBI, INC | 1 | $21 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
Products named: REBLOZYL, SARCLISA, RYLAZE, PREVYMIS, ZERBAXA, REVUFORJ, Vonjo, REZUROCK.
Industry payments across CO — which companies pay providers there.
